Angiotensin converting enzyme (ACE) inhibitors can adversely effect both the fetus and newborn primarily because of its effects on the fetal kidney.
Example of ACE inhibitors: captopril, enalapril, lisinopril, quinapril, fosinopril
Timing of adverse effects: when taken during the second and third trimester (not the first)
Organs affected:
(1) renal
(2) pulmonary
(3) osseous (calvarium)
Renal effects:
(1) renal tubular dysplasia
(2) renal failure with oliguria or anuria
Respiratory effects: pulmonary hypoplasia
Osseous changes:
(1) decreased skull ossification
(2) hypocalvaria or acalvaria
Additional physiologic effects on the fetus:
(1) vasodilation and hypotension
(2) oligohydramnios
(3) limb deformities
Purpose: To determine if a neonate shows evidence of adverse effects associated with maternal use of an angiotensin converting enzyme (ACE) inhibitor.
Specialty: Pedatrics, Pharmacology, clinical
Objective: response to therapy, adverse effects
ICD-10: Y52.4,